Evidence map›Paper›PMID 17452355›Full record

ArticleNucleic acids research2007

Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA.

Christopher M Barbieri, Annankoil R Srinivasan, Suzanne G Rzuczek, Joseph E Rice, Edmond J LaVoie, Daniel S Pilch

Abstract read
In one paragraph

Article in Nucleic acids research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A G-quadruplex stabilizer induces M-phase cell cycle arrest.The Journal of biological chemistry · 2009
    Article
  14. Article
  15. Article
  16. Article
  17. End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2007
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher M BarbieriDepartment of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854-5635, USA.
Annankoil R Srinivasan
Suzanne G Rzuczek
Joseph E Rice
Edmond J LaVoie
Daniel S Pilch

Funding

Training in Cancer PharmacologyT32CA108455 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LIU, LEROY F · 2005 to 2009
$1.3M
DNA Minor Groove-Targeting Anticancer AgentsR01CA097123 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PILCH, DANIEL S · 2003 to 2006
$1.0M
Benzo[i]phenanthridines: TOP1-Targeting Antitumor AgentsR01CA098127 · NCI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI LAVOIE, EDMOND J · 2004 to 2006
$709k
NCI NIH HHS CA097123NCI NIH HHS CA098127NCI NIH HHS R01 CA097123NCI NIH HHS R01 CA098127NCI NIH HHS T32 CA108455
6 · The paper itself

Abstract

Oxazole-containing macrocycles represent a promising class of anticancer agents that target G-quadruplex DNA. We report the results of spectroscopic studies aimed at defining the mode, energetics and specificity with which a hexaoxazole-containing macrocycle (HXDV) binds to the intramolecular quadruplex formed by the human telomeric DNA model oligonucleotide d(T2AG3)4 in the presence of potassium ions. HXDV binds solely to the quadruplex nucleic acid form, but not to the duplex or triplex form. HXDV binds d(T2AG3)4 with a stoichiometry of two drug molecules per quadruplex, with these binding reactions being coupled to the destacking of adenine residues from the terminal G-tetrads. HXDV binding to d(T2AG3)4 does not alter the length of the quadruplex. These collective observations are indicative of a nonintercalative 'terminal capping' mode of interaction in which one HXDV molecule binds to each end of the quadruplex. The binding of HXDV to d(T2AG3)4 is entropy driven, with this entropic driving force reflecting contributions from favorable drug-induced alterations in the configurational entropy of the host quadruplex as well as in net hydration. The 'terminal capping' mode of binding revealed by our studies may prove to be a general feature of the interactions between oxazole-containing macrocyclic ligands (including telomestatin) and intramolecular DNA quadruplexes.

Indexed as

2-AminopurineAdenineAntineoplastic AgentsBinding SitesDNAEntropyG-QuadruplexesHumansLigandsModels, MolecularNucleic Acid ConformationOxazolesSpectrometry, FluorescenceTelomere2-AminopurineAdenineAntineoplastic AgentsDNALigandsOxazoles

Identifiers

PMID17452355
PMCPMC1904271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.